
Shanghai RAAS Blood Products Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Shanghai RAAS Blood Products Co Ltd
Access all reports
Shanghai RAAS Blood Products Co., Ltd. is a Chinese healthcare company focused on the research, development, production, and distribution of plasma-derived biopharmaceutical products. The company produces a variety of blood plasma-based therapies, including immunoglobulins, albumin, and coagulation factor products, used in the treatment of immune deficiencies, blood disorders, and other medical conditions. The company is headquartered in Shanghai, China, and its shares are listed on the Shenzhen Stock Exchange.
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
002252
Country
🇨🇳 China